aDepartment of Psychiatry & Behavioral Sciences, University of California, San Francisco, CA;

bWhole Person Integrated Care, San Francisco Department of Public Health, San Francisco, CA; and

cDivision of HIV, ID & Global Medicine, Department of Medicine, University of California, San Francisco, CA.

Correspondence to: Nicky J. Mehtani, MD, MPH, Department of Psychiatry & Behavioral Sciences, University of California, 675 Nelson Rising Lane, Sandler Neurosciences Bldg., Rm 510, San Francisco, CA 94143 (e-mail: [email protected]).

Preparation of this manuscript was supported by the National Institutes of Drug Abuse [T32DA007250 to NJM] and by the UCSF AIDS Research Institute [CFAR-ARI Boost Award].

Association for Multidisciplinary Education & Research on Substance Abuse (AMERSA) Conference in Boston, MA; November 10–12, 2022.

The authors have no funding or conflicts of interest to disclose.

Conceptualization, N.J.M.; Implementation, N.J.M., A.S., and S.S.; Writing—Original Draft Preparation, N.J.M.; Writing—Review & Editing, M.G., E.D.R., A.S., S.S., B.Z., and J.E.; Supervision, M.G., B.Z., and J.E.; Funding Acquisition, B.Z., J.E., and N.J.M.